These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30636205)

  • 1. Subcutaneous dexmedetomidine for baclofen withdrawal during palliative sedation.
    Laroche JP
    BMJ Support Palliat Care; 2020 Mar; 10(1):7-9. PubMed ID: 30636205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteral baclofen withdrawal managed with intravenous dexmedetomidine: A case report.
    Defayette A; Perrello A; Brewer T; Picano J; Ahmed S
    Am J Health Syst Pharm; 2020 Feb; 77(5):352-355. PubMed ID: 31930325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous dexmedetomidine infusions to treat or prevent drug withdrawal in infants and children.
    Tobias JD
    J Opioid Manag; 2008; 4(4):187-91. PubMed ID: 18837201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine for acute baclofen withdrawal.
    Morr S; Heard CM; Li V; Reynolds RM
    Neurocrit Care; 2015 Apr; 22(2):288-92. PubMed ID: 25403764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients.
    Baddigam K; Russo P; Russo J; Tobias JD
    J Intensive Care Med; 2005; 20(2):118-23. PubMed ID: 15855224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal.
    Multz AS
    Anesth Analg; 2003 Apr; 96(4):1054-1055. PubMed ID: 12651659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature.
    Kukoyi A; Coker S; Lewis L; Nierenberg D
    Hum Exp Toxicol; 2013 Jan; 32(1):107-10. PubMed ID: 23111887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal.
    Mueller SW; Preslaski CR; Kiser TH; Fish DN; Lavelle JC; Malkoski SP; MacLaren R
    Crit Care Med; 2014 May; 42(5):1131-9. PubMed ID: 24351375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database.
    Baumgartner K; Doering And M; Mullins ME;
    Clin Toxicol (Phila); 2022 Dec; 60(12):1356-1375. PubMed ID: 36346349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using dexmedetomidine as adjunctive therapy for patients with severe alcohol withdrawal syndrome: another piece of the puzzle.
    Savel RH; Kupfer Y
    Crit Care Med; 2014 May; 42(5):1298-9. PubMed ID: 24736345
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of adjunctive dexmedetomidine in the management of severe acute alcohol withdrawal syndrome.
    Wong A; Smithburger PL; Kane-Gill SL
    Am J Drug Alcohol Abuse; 2015; 41(5):382-91. PubMed ID: 26337198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine as a strategy for discontinuing dexmedetomidine sedation in critically ill patients: A narrative review.
    Glaess SS; Attridge RL; Christina Gutierrez G
    Am J Health Syst Pharm; 2020 Mar; 77(7):515-522. PubMed ID: 32086509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.
    Frazee EN; Personett HA; Leung JG; Nelson S; Dierkhising RA; Bauer PR
    J Crit Care; 2014 Apr; 29(2):298-302. PubMed ID: 24360597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
    Ferenchak TA
    J Addict Nurs; 2017; 28(4):188-195. PubMed ID: 29200045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical uses of dexmedetomidine in pediatric patients.
    Phan H; Nahata MC
    Paediatr Drugs; 2008; 10(1):49-69. PubMed ID: 18162008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe GHB withdrawal delirium managed with dexmedetomidine.
    Tay EM; Graham RI; Day RO
    Med J Aust; 2016 Sep; 205(6):251-2. PubMed ID: 27627929
    [No Abstract]   [Full Text] [Related]  

  • 17. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
    Ferenchak TA
    J Addict Nurs; 2017; 28(4):E1-E2. PubMed ID: 29200055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged sedation in critically ill children: is dexmedetomidine a safe option for younger age? An off-label experience.
    Sperotto F; Mondardini MC; Vitale F; Daverio M; Campagnano E; Ferrero F; Rossetti E; Vasile B; Dusio MP; Ferrario S; Savron F; Brugnaro L; Amigoni A;
    Minerva Anestesiol; 2019 Feb; 85(2):164-172. PubMed ID: 30394067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine Use in a Tertiary Care NICU: A Descriptive Study.
    Dersch-Mills DA; Banasch HL; Yusuf K; Howlett A
    Ann Pharmacother; 2019 May; 53(5):464-470. PubMed ID: 30501499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.